The New York Stem Cell Foundation supports translational stem cell research through grants to scientists working on stem cell research in the NYSCF laboratory or their own laboratories. The Medical Advisory Board advises on criteria for grants that are formatted along NIH guidelines and are consistent with NYSCF's mission.

Current NYSCF - Druckenmiller Fellows

Post-Doctoral Research Fellowships

Three-year NYSCF Research Fellowships are offered to post-docs to pursue work in the area of hESC, SCNT, and iPS research. NYSCF’s post-doctoral Fellowship Program encourages the brightest junior scientists to pursue stem cell research, countering the chilling effect that Federal funding restrictions have had on the field. The fellows represent an elite group of postdoctoral investigators who are doing innovative and groundbreaking research in the field of regenerative medicine.

The program was created to ensure that a generation of researchers has the knowledge and expertise to lead this research as the field grows.  In addition to an annual stipend, each Fellow has access to NYSCF’s laboratory, and participates in our annual conference.

The Fellowship Program has been generously supported by Stanley and Fiona Druckenmiller.  Additional support has been provided by an anonymous donor and by The Shelley & Donald Rubin Foundation.

Download the 2010 Fellowship Request for Application

Download the 2010 application cover sheet

DEADLINE: Applications will be due at 5:00 PM (EST) on January 15, 2010.  


Grants to Senior Scientists

NYSCF supports senior scientists doing translational stem cell research and encourages the use of its laboratory by all grantees.  These researchers collaborate on cutting-edge human embryonic stem cell work.  Current projects include:

• Creation of disease-specific stem cell lines for Type 1 and Type 2 Diabetes.
• Differentiation of human embryonic stem cells into dopaminergic neurons lost in Parkinson's disease.
• Examination of new ways to model the neuro-degenerative disease ALS.
• Derivation of human cardiac progenitor cells and transplantation of the cells into large animal models.